Ion Transport Mechanisms in Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) arises from complex interactions between genetic susceptibility, immune dysregulation and environmental triggers, with a central role played by dysregulated ion transport within the intestinal mucosa. Key epithelial transporters, including the Na⁺/H⁺ exchanger NHE3 and the Cl⁻/HCO₃⁻ exchanger DRA (SLC26A3), maintain luminal homeostasis by coordinating absorption of sodium, chloride and bicarbonate. In IBD, pro-inflammatory cytokines reduce NHE3 activity via decreased expression or disrupted interactions with PDZ adaptor proteins such as NHERF2 and PDZK1, while DRA expression is often down-regulated, leading to impaired chloride absorption and diarrhoea. Compensatory up-regulation of alternative transporters, barrier dysfunction and shifts in luminal osmolarity further exacerbate fluid loss. Emerging models using organoids, conditional gene knock-outs and epithelial cell lines under hyperosmolar or cytokine-rich environments have elucidated the molecular feedback loops between ion transporters, inflammatory signalling pathways and epithelial renewal. This interface shapes barrier integrity, cell proliferation and microbial community structure, underpinning disease chronicity. Targeting specific transport pathways or their regulatory adaptors holds promise for restoring electrolyte balance and mucosal healing in IBD.

Research from Nature Portfolio

Recent in vitro work has demonstrated that increased luminal osmolarity, as may occur during diarrhoeal episodes, transiently impairs mitochondrial respiration and decreases intracellular ATP in colonocytes. This energetic stress diminishes barrier function by altering tight junction permeability and modifies paracellular ion flux, enabling partial osmotic equilibration. Acute hyperosmotic exposure also triggers IL-8 secretion and a temporally distinct transcriptional response in genes controlling energy metabolism and electrolyte transport. Such adaptive responses highlight the epithelial capacity to sense osmotic changes and adjust transporter expression and junctional integrity, with implications for barrier restoration strategies in inflamed mucosa.

Ion Transport Mechanisms in Inflammatory Bowel Disease publication trend

The graph below shows the total number of articles in ion transport mechanisms in inflammatory bowel disease across all publications each year (not limited to Nature Index journals).

Technical terms

Na⁺/H⁺ exchanger (NHE3): An apical epithelial transporter exchanging sodium for protons to facilitate sodium absorption and pH regulation.

Cl⁻/HCO₃⁻ exchanger (DRA/SLC26A3): A membrane protein mediating electroneutral exchange of chloride and bicarbonate ions to support chloride absorption and acid–base balance.

PDZ adaptor proteins: Cytosolic scaffolds (e.g. NHERF2, PDZK1) that tether ion transporters to signalling complexes and affect their localisation and activity.

Hyperosmolarity: An environment with elevated solute concentration that alters cell volume, metabolism and barrier permeability.

Short-chain fatty acids (SCFAs): Microbial metabolites (e.g. acetate, butyrate) that modulate epithelial energy metabolism, signalling and immune responses.

References

1. Mouse Down-regulated in Adenoma (DRA) Is an Intestinal Cl−/HCO3 − Exchanger and Is Up-regulated in Colon of Mice Lacking the NHE3 Na+/H+Exchanger*. Journal of Biological Chemistry (1999).
2. slc26a3 (dra)-deficient Mice Display Chloride-losing Diarrhea, Enhanced Colonic Proliferation, and Distinct Up-regulation of Ion Transporters in the Colon*. Journal of Biological Chemistry (2006).
3. Hyperosmolar environment and intestinal epithelial cells: impact on mitochondrial oxygen consumption, proliferation, and barrier function in vitro. Scientific Reports (2019).
4. Downregulation of the NHE3-Binding PDZ-Adaptor Protein PDZK1 Expression during Cytokine-Induced Inflammation in Interleukin-10–Deficient Mice. PLOS ONE (2012).
5. IL-1β-Induced Downregulation of the Multifunctional PDZ Adaptor PDZK1 Is Attenuated by ERK Inhibition, RXRα, or PPARα Stimulation in Enterocytes. Frontiers in Physiology (2017).
6. Intestine-Specific NHE3 Deletion in Adulthood Causes Microbial Dysbiosis. Frontiers in Cellular and Infection Microbiology (2022).